Cui Zeng
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Clostridium difficile and Clostridium perfringens research 3
- Oncology 3
- Co-authors
- Chunhui Li (5 shared papers)Anhua Wu (5 shared papers)Chenchao Fu (5 shared papers)Xiujuan Meng (4 shared papers)Sidi Liu (4 shared papers)Kaifang Zou (4 shared papers)Juping Duan (3 shared papers)Liangru Zhu (3 shared papers)
- Journals
- International Immunopharmacology (2 papers)PLoS ONE (2 papers)Frontiers in Medicine (2 papers)Medicine (1 paper)Infection (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Cui Zeng
18 papers receiving 298 citations
Peers
Comparison fields: 5 of 84
- Applied Microbiology and Biotechnology 12
- Hepatology 24
- Critical Care and Intensive Care Medicine 12
- Infectious Diseases 44
- Oncology 58
Countries citing papers authored by Cui Zeng
This map shows the geographic impact of Cui Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cui Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cui Zeng more than expected).
Fields of papers citing papers by Cui Zeng
This network shows the impact of papers produced by Cui Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cui Zeng. The network helps show where Cui Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Cui Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 56 | |
| 2 | 2017 | 45 | |
| 3 | 2019 | 38 | |
| 4 | 2020 | 33 | |
| 5 | 2013 | 24 | |
| 6 | 2017 | 24 | |
| 7 | 2013 | 19 | |
| 8 | 2021 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 9 | |
| 11 | 2018 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2023 | 4 | |
| 14 | 2024 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2013 | 2 | |
| 18 | 2022 | 1 |
About Cui Zeng
Cui Zeng is a scholar working on Infectious Diseases, Oncology, Epidemiology, Pulmonary and Respiratory Medicine and Surgery, having authored 18 papers that have together received 305 indexed citations. Recurring topics across this work include Microscopic Colitis (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Infection Control and Ventilation (1 paper), Ferroptosis and cancer prognosis (1 paper), Fatty Acid Research and Health (1 paper), Antibiotic Use and Resistance (1 paper), Retinal Imaging and Analysis (1 paper) and Retinal Diseases and Treatments (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (12 citations), Hepatology (24 citations), Critical Care and Intensive Care Medicine (12 citations), Infectious Diseases (44 citations) and Oncology (58 citations). Cui Zeng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chunhui Li, Anhua Wu, Chenchao Fu, Xiujuan Meng, Sidi Liu, Kaifang Zou, Juping Duan, Liangru Zhu, Xiaohua Hou and Shengli Yang. Their work appears in journals such as International Immunopharmacology, PLoS ONE, Frontiers in Medicine, Medicine and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.